Your browser doesn't support javascript.
loading
Design of protein-binding proteins from the target structure alone.
Cao, Longxing; Coventry, Brian; Goreshnik, Inna; Huang, Buwei; Sheffler, William; Park, Joon Sung; Jude, Kevin M; Markovic, Iva; Kadam, Rameshwar U; Verschueren, Koen H G; Verstraete, Kenneth; Walsh, Scott Thomas Russell; Bennett, Nathaniel; Phal, Ashish; Yang, Aerin; Kozodoy, Lisa; DeWitt, Michelle; Picton, Lora; Miller, Lauren; Strauch, Eva-Maria; DeBouver, Nicholas D; Pires, Allison; Bera, Asim K; Halabiya, Samer; Hammerson, Bradley; Yang, Wei; Bernard, Steffen; Stewart, Lance; Wilson, Ian A; Ruohola-Baker, Hannele; Schlessinger, Joseph; Lee, Sangwon; Savvides, Savvas N; Garcia, K Christopher; Baker, David.
Afiliação
  • Cao L; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Coventry B; Institute for Protein Design, University of Washington, Seattle, WA, USA.
  • Goreshnik I; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Huang B; Institute for Protein Design, University of Washington, Seattle, WA, USA.
  • Sheffler W; Molecular Engineering Graduate Program, University of Washington, Seattle, WA, USA.
  • Park JS; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Jude KM; Institute for Protein Design, University of Washington, Seattle, WA, USA.
  • Markovic I; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Kadam RU; Institute for Protein Design, University of Washington, Seattle, WA, USA.
  • Verschueren KHG; Department of Bioengineering, University of Washington, Seattle, WA, USA.
  • Verstraete K; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Walsh STR; Institute for Protein Design, University of Washington, Seattle, WA, USA.
  • Bennett N; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.
  • Phal A; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Yang A; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Kozodoy L; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
  • DeWitt M; VIB-UGent Center for Inflammation Research, Ghent, Belgium.
  • Picton L; Unit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
  • Miller L; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Strauch EM; VIB-UGent Center for Inflammation Research, Ghent, Belgium.
  • DeBouver ND; Unit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
  • Pires A; VIB-UGent Center for Inflammation Research, Ghent, Belgium.
  • Bera AK; Unit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
  • Halabiya S; Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Hammerson B; J.A.M.E.S. Farm, Clarksville, MD, USA.
  • Yang W; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Bernard S; Institute for Protein Design, University of Washington, Seattle, WA, USA.
  • Stewart L; Molecular Engineering Graduate Program, University of Washington, Seattle, WA, USA.
  • Wilson IA; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Ruohola-Baker H; Department of Bioengineering, University of Washington, Seattle, WA, USA.
  • Schlessinger J; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
  • Lee S; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Savvides SN; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Garcia KC; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Baker D; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Nature ; 605(7910): 551-560, 2022 05.
Article em En | MEDLINE | ID: mdl-35332283
ABSTRACT
The design of proteins that bind to a specific site on the surface of a target protein using no information other than the three-dimensional structure of the target remains a challenge1-5. Here we describe a general solution to this problem that starts with a broad exploration of the vast space of possible binding modes to a selected region of a protein surface, and then intensifies the search in the vicinity of the most promising binding modes. We demonstrate the broad applicability of this approach through the de novo design of binding proteins to 12 diverse protein targets with different shapes and surface properties. Biophysical characterization shows that the binders, which are all smaller than 65 amino acids, are hyperstable and, following experimental optimization, bind their targets with nanomolar to picomolar affinities. We succeeded in solving crystal structures of five of the binder-target complexes, and all five closely match the corresponding computational design models. Experimental data on nearly half a million computational designs and hundreds of thousands of point mutants provide detailed feedback on the strengths and limitations of the method and of our current understanding of protein-protein interactions, and should guide improvements of both. Our approach enables the targeted design of binders to sites of interest on a wide variety of proteins for therapeutic and diagnostic applications.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Proteínas de Transporte Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Proteínas de Transporte Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article